About Colin Collins
Colin Collins is a chief scientific officer and co-founder, director at Hexamer Therapeutics.
Colin Collins first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Colin Collins in the role, so the role may have started earlier or lasted longer.
Hexamer Therapeutics, Inc
Chief Scientific Officer and Co-Founder, director
2019 – 2026 · Pullman, WA
Develops vaccine technologies for human cancer and infectious diseases and for animal health companies.
Key Colleagues at Startups
The people Colin Collins works with at each company, as listed on that company's latest Form D.
Hexamer Therapeutics, Inc · Form D, Sep 15, 2026
Robert Bogden
Chief Executive Officer (CEO) and director
BC
Brad Call
Director
RB
R. Scott Blackley
Director
Keith Miller
Chief Technology Officer (CTO) and director
SC
Stephen Crawford
Director